Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

89Zr

  • Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer
    You have access
    Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer
    Kelly E. Henry, Travis M. Shaffer, Kyeara N. Mack, Janine Ring, Anuja Ogirala, Susanne Klein-Scory, Christina Eilert-Micus, Wolff Schmiegel, Thilo Bracht, Barbara Sitek, Marguerite Clyne, Colm J. Reid, Bence Sipos, Jason S. Lewis, Holger Kalthoff and Jan Grimm
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1384-1390; DOI: https://doi.org/10.2967/jnumed.120.256776
  • 
<sup>89</sup>Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    You have access
    89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression
    Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho and Kyung-Han Lee
    Journal of Nuclear Medicine May 10, 2021, 62 (5) 656-664; DOI: https://doi.org/10.2967/jnumed.120.250720
  • You have access
    Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
    Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara and Buck E. Rogers
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 137-143; DOI: https://doi.org/10.2967/jnumed.120.249557
  • You have access
    Light-Induced Radiosynthesis of 89Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor
    Simon Klingler, Rachael Fay and Jason P. Holland
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 1072-1078; DOI: https://doi.org/10.2967/jnumed.119.237180
  • You have access
    89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
    Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber and Marc C. Huisman
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1825-1832; DOI: https://doi.org/10.2967/jnumed.118.224568
  • You have access
    Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
    Jorge A. Carrasquillo, Bernard M. Fine, Neeta Pandit-Taskar, Steven M. Larson, Stephen E. Fleming, Josef J. Fox, Sarah M. Cheal, Joseph A. O’Donoghue, Shutian Ruan, Govind Ragupathi, Serge K. Lyashchenko, John L. Humm, Howard I. Scher, Mithat Gönen, Simon P. Williams, Daniel C. Danila and Michael J. Morris
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1517-1523; DOI: https://doi.org/10.2967/jnumed.118.222844
  • You have access
    Fully Automated 89Zr Labeling and Purification of Antibodies
    Alex J. Poot, Kevin W.A. Adamzek, Albert D. Windhorst, Maria J.W.D. Vosjan, Saskia Kropf, Hans-Jurgen Wester, Guus A.M.S. van Dongen and Danielle J. Vugts
    Journal of Nuclear Medicine May 1, 2019, 60 (5) 691-695; DOI: https://doi.org/10.2967/jnumed.118.217158
  • Open Access
    Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
    Thomas A. Burley, Chiara Da Pieve, Carlos D. Martins, Daniela M. Ciobota, Louis Allott, Wim J.G Oyen, Kevin J. Harrington, Graham Smith and Gabriela Kramer-Marek
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 353-361; DOI: https://doi.org/10.2967/jnumed.118.216069
  • You have access
    An Overview of PET Radiochemistry, Part 2: Radiometals
    Marie Brandt, Jens Cardinale, Margaret L. Aulsebrook, Gilles Gasser and Thomas L. Mindt
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1500-1506; DOI: https://doi.org/10.2967/jnumed.117.190801
  • You have access
    In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody–Drug Conjugates: Taking Advantage of Dual Labeling with 195mPt and 89Zr
    Joey A. Muns, Veronica Montserrat, Hendrik-Jan Houthoff, Karlijn Codée-van der Schilden, Oene Zwaagstra, Niels J. Sijbrandi, Eugen Merkul and Guus A.M.S. van Dongen
    Journal of Nuclear Medicine July 1, 2018, 59 (7) 1146-1151; DOI: https://doi.org/10.2967/jnumed.117.206672

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire